Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 10, 2026

Hemagen Diagnostics Company Description

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide.

The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins.

Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases.

It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines.

In addition, the company offers veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas.

Its products are used in laboratories, hospitals and blood banks. Hemagen Diagnostics, Inc. was incorporated in 1985 and is based in Columbia, Maryland.

Hemagen Diagnostics, Inc.
CountryUnited States
Founded1985
IndustryBiotechnology
SectorHealthcare
Employees15
CEOWilliam Hales

Contact Details

Address:
9033 Red Branch Road
Columbia, Maryland 21045
United States
Phone443-367-5500
Websitehemagen.com

Stock Details

Ticker SymbolHMGN
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearOctober - September
Reporting CurrencyUSD
ISIN NumberUS4235011057
SIC Code2835

Key Executives

NamePosition
William P. HalesExecutive Chairman, Chief Executive Officer and President
M. Robert CampbellChief Financial Officer and Chief Operating Officer